Alessandro Ceschi

8.0k total citations
94 papers, 1.5k citations indexed

About

Alessandro Ceschi is a scholar working on Emergency Medicine, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alessandro Ceschi has authored 94 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Emergency Medicine, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alessandro Ceschi's work include Poisoning and overdose treatments (26 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Alessandro Ceschi is often cited by papers focused on Poisoning and overdose treatments (26 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Alessandro Ceschi collaborates with scholars based in Switzerland, Italy and United States. Alessandro Ceschi's co-authors include Roberta Noseda, Hugo Kupferschmidt, Christine Rauber‐Lüthy, Gerd A. Kullak‐Ublick, Katia Verhamme, Karine Palin, Michael Bodmer, Chiara Di Lorenzo, Patrizia Restani and Markus Gnädinger and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Alessandro Ceschi

88 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Ceschi Switzerland 22 205 203 196 187 187 94 1.5k
David Czock Germany 23 435 2.1× 259 1.3× 105 0.5× 226 1.2× 328 1.8× 111 2.3k
Facundo García‐Bournissen Canada 28 250 1.2× 194 1.0× 57 0.3× 185 1.0× 124 0.7× 135 2.6k
Sonia Radice Italy 27 161 0.8× 215 1.1× 55 0.3× 73 0.4× 175 0.9× 112 1.7k
Stefano D’Errico Italy 24 110 0.5× 270 1.3× 193 1.0× 93 0.5× 258 1.4× 121 1.7k
Alfonso Carvajal Spain 20 237 1.2× 86 0.4× 49 0.3× 94 0.5× 106 0.6× 63 1.6k
Walter K. Kraft United States 29 161 0.8× 213 1.0× 64 0.3× 189 1.0× 283 1.5× 128 2.5k
Yechiel A. Hekster Netherlands 29 279 1.4× 175 0.9× 155 0.8× 162 0.9× 753 4.0× 73 2.7k
Milou‐Daniel Drici France 21 136 0.7× 534 2.6× 53 0.3× 68 0.4× 264 1.4× 73 1.6k
Céline M. Laffont France 22 364 1.8× 147 0.7× 55 0.3× 208 1.1× 92 0.5× 48 1.7k
Kim Kristensen Denmark 27 111 0.5× 257 1.3× 50 0.3× 86 0.5× 198 1.1× 65 2.2k

Countries citing papers authored by Alessandro Ceschi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Ceschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Ceschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Ceschi more than expected).

Fields of papers citing papers by Alessandro Ceschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Ceschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Ceschi. The network helps show where Alessandro Ceschi may publish in the future.

Co-authorship network of co-authors of Alessandro Ceschi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Ceschi. A scholar is included among the top collaborators of Alessandro Ceschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Ceschi. Alessandro Ceschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abolhassani, Nazanin, Roberta Noseda, Kim Dao, et al.. (2025). Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in V igi B ase. Clinical and Translational Science. 18(12). e70429–e70429.
2.
Ceschi, Alessandro, et al.. (2024). Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal study. Swiss Medical Weekly. 154(11). 3409–3409. 2 indexed citations
3.
Noseda, Roberta, et al.. (2023). Safety of monoclonal antibodies targeting PCSK9 in pregnancy: Analysis of the WHO's global pharmacovigilance database. Neurotoxicology and Teratology. 98. 107242–107242. 1 indexed citations
4.
Noseda, Roberta, Matteo Franchi, Alberto Pagnamenta, et al.. (2023). Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study. Journal of Clinical Medicine. 12(18). 5970–5970. 7 indexed citations
5.
Singer, Mathias Van, J. Koch, Andrea M. Weckman, et al.. (2023). Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19. BMC Infectious Diseases. 23(1). 630–630.
6.
Vallersnes, Odd Martin, Alison M. Dines, David M. Wood, et al.. (2023). Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries. International Journal of Emergency Medicine. 16(1). 86–86. 2 indexed citations
7.
Rothuizen, Laura E., et al.. (2022). Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines. International Journal of Audiology. 62(6). 587–591. 17 indexed citations
8.
Low, Jun Siong, Federico Mele, Mathilde Foglierini, et al.. (2021). Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science. 372(6548). 1336–1341. 85 indexed citations
9.
Noseda, Roberta, et al.. (2021). Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase. Vaccines. 9(9). 1022–1022. 13 indexed citations
10.
Cippà, Pietro E., Federica Cugnata, Paolo Ferrari, et al.. (2020). A data-driven approach to identify risk profiles and protective drugs in COVID-19. Proceedings of the National Academy of Sciences. 118(1). 20 indexed citations
11.
Gottardi, Andrea De, et al.. (2020). Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection. Clinics and Research in Hepatology and Gastroenterology. 44(6). e141–e144. 4 indexed citations
13.
Noseda, Roberta, et al.. (2019). Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports. Journal for ImmunoTherapy of Cancer. 7(1). 117–117. 52 indexed citations
15.
Gnädinger, Markus, Alessandro Ceschi, Dieter Conen, et al.. (2015). Medication incidents in primary care medicine: protocol of a study by the Swiss Federal Sentinel Reporting System. BMJ Open. 5(4). e007773–e007773. 6 indexed citations
16.
Vecchio, Stefania, Stéphanie Tellier, Heli Mustonen, et al.. (2013). Retrospective poisons centres-based study on adverse effects due to plant food supplements. Clinical Toxicology. 51(4). 267–268. 1 indexed citations
18.
Rauber‐Lüthy, Christine, et al.. (2013). Medication wrong route administration: a poisons center-based study. Expert Opinion on Drug Safety. 12(2). 145–152. 1 indexed citations
19.
Rauber‐Lüthy, Christine, et al.. (2012). Ketamine-like Effects After Recreational Use of Methoxetamine. Annals of Emergency Medicine. 60(1). 97–99. 67 indexed citations
20.
Rauber‐Lüthy, Christine, et al.. (2010). Minimal Dose for Severe Poisoning and Influencing Factors in Acute Human Clozapine Intoxication. Clinical Neuropharmacology. 33(5). 230–234. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026